ASCO 2020 Press Releases

Viewing 1-11 of 11 articles

Epic Sciences to Present Multiple Abstracts at ASCO 2020 Highlighting the Importance of CTCs in Liquid Biopsy Data Characterizes the Role of CTCs in Cancer Prognosis and Patient Care

Phase III Trial Shows Avelumab an Immunotherapy Treatment for Advanced Urothelial Cancer Prolongs Overall Survival

Immunotherapy Following Chemotherapy Offers Extended Survival to Patients with Advanced Urothelial Cancer

Darolutamide Plus Androgen Deprivation Therapy Showed Significant Improvement in Overall Survival with Proven Efficacy and Tolerability in Men with Non-Metastatic Castration-Resistant Prostate Cancer

Early Data Show Cancer Progression Associated With Increased Risk of Death in Patients With COVID-19

Integrating Geriatric Assessment and Management Into Cancer Care Improves Quality of Life, Reduces Hospital Admissions for Older Patients

Foundation Medicine and Collaborators to Share New Data During the ASCO20 Virtual Scientific Program Showcasing the Importance of Comprehensive Genomic Profiling (CGP) in Informing Advanced Cancer Clinical Decision-Making

Videoconference Intervention Significantly Reduces Anxiety and Distress Among Remote Caregivers of People With Cancer

Results from COSMIC-021 Trial Announced: Cabozanitinib in Combination with Atezolizumab with Multiple Advanced Solid Tumor Types

Greater Decline in Cancer-Related Deaths Seen in Medicaid Expansion States in First Nationwide Study

Special Report Provides Guidance to Oncology Practices on Resuming Cancer Care During COVID-19 Pandemic